OBIO
Orchestra BioMed Holdings Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$228.23M
P/E Ratio
—
EPS
$-1.11
Beta
0.60
52W High
$5.42
52W Low
$2.20
50-Day MA
$4.34
200-Day MA
$3.76
Dividend Yield
—
Profit Margin
-157.40%
Forward P/E
—
PEG Ratio
—
About Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings, Inc. is a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. The company is headquartered in New Hope, Pennsylvania.
Fundamentals
| Revenue (TTM) | $33.48M |
| Gross Profit (TTM) | $33.29M |
| EBITDA | $-51.48M |
| Operating Margin | 21.80% |
| Return on Equity | -109.40% |
| Return on Assets | -33.90% |
| Revenue/Share (TTM) | $0.70 |
| Book Value | $0.94 |
| Price-to-Book | 4.26 |
| Price-to-Sales (TTM) | 6.82 |
| EV/Revenue | 4.112 |
| EV/EBITDA | -1.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 12120.00% |
| Shares Outstanding | $58.52M |
| Float | $32.49M |
| % Insiders | 27.92% |
| % Institutions | 38.23% |
Historical Volatility
HV 10-Day
38.84%
HV 20-Day
44.04%
HV 30-Day
43.75%
HV 60-Day
60.79%
HV Rank
0.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($12.43 target)
2
Strong Buy5
Buy1
HoldData last updated: 4/29/2026